FDA Grants Fast Track Designation to Diffuse Large B-Cell Lymphoma Drug Candidate
According to a press release from the New Jersey-based biotechnology company Cellectar Biosciences, the Food and Drug Administration (FDA) has granted "Fast Track" designation to the Company's experimental diffuse large…